معرفی
Dr. Sumati Bhatia is a Senior Lecturer in Chemistry at Swansea University's Faculty of Science and Engineering, specializing in biomacromolecular chemistry and glycomaterials research. Her work focuses on engineering glycomaterials to combat various pathogens including Influenza A viruses, SARS-CoV-2, Herpes Simplex virus, E. coli, and Pseudomonas aeruginosa. With over 40 research articles and 7 patent applications, she leads an active research program at the intersection of chemistry, biology, physics, and emerging technologies.
Her research interests center on developing glyco-based synthetic tools to gain experimental insights into infection-related processes. Dr. Bhatia's expertise spans glycomaterials, antimicrobials, polymer chemistry, drug delivery systems, sustainable chemistry, and biomacromolecules. She actively pursues interdisciplinary collaborations, particularly exploring how AI and machine learning can enhance pathogen inhibition strategies. Her work bridges fundamental chemical principles with practical biomedical applications, focusing on multivalent inhibitor design for pathogen neutralization.
Analysis of her recent publications reveals a strong focus on glyco-engineered materials for pathogen inhibition, with particular emphasis on influenza viruses, SARS-CoV-2, and bacterial pathogens. Her research demonstrates sophisticated understanding of multivalent binding principles, nanomaterial design, and structure-activity relationships in pathogen inhibition. The work spans from fundamental studies of binding forces to applied therapeutic development, with increasing integration of nanotechnology approaches.
Scientific Awards and Recognition:
- 2024-2025: Research grant from the Royal Society of Chemistry
- 2024-2027: Research grant from Novo Nordisk Foundation for pandemic anti-influenza drug development
- 2022: Research-based teaching award from Berlin University Alliance
- 2022: Shortlisted for the Reimund Stadler Prize
- 2021: Selected for ProFiL programme for professionalization of women in research and teaching
Dr. Bhatia is actively involved in postgraduate supervision and has secured substantial research funding including grants from the German Science Foundation (2021-2024) and Berlin University Alliance (2020-2021). Her international collaborations span Germany, UK, USA, France, Spain, Mexico, and India, reflecting the global impact of her work. She maintains strong industry connections through her research on practical therapeutic applications of glycomaterials.
Her laboratory focuses on developing innovative glyco-based materials for pathogen inhibition, with particular emphasis on multivalent binding principles. The research group employs interdisciplinary approaches combining synthetic chemistry, biophysical characterization, and biological testing to develop next-generation antimicrobial and antiviral materials. Current projects include development of pandemic-ready anti-influenza therapeutics and novel materials for combating antibiotic-resistant bacteria.
